Mapping of molecular pathways, biomarkers and drug targets for diabetic nephropathy (Q44871811)

7 December 2017

Mapping of molecular pathways, biomarkers and drug targets for diabetic nephropathy (English)

1 reference

7 December 2017

1 reference

8

Doron Lancet

1 reference

7 December 2017

Raul Fechete

1

1 reference

7 December 2017

Andreas Heinzel

2

1 reference

7 December 2017

Paul Perco

3

1 reference

7 December 2017

Konrad Mönks

4

1 reference

7 December 2017

Johannes Söllner

5

1 reference

7 December 2017

Gil Stelzer

6

1 reference

7 December 2017

Susanne Eder

7

1 reference

7 December 2017

Rainer Oberbauer

9

1 reference

7 December 2017

Gert Mayer

10

1 reference

7 December 2017

Bernd Mayer

11

1 reference

7 December 2017

14 April 2011

1 reference

Proteomics - Clinical Applications

7 December 2017

1 reference

7 December 2017

5

1 reference

7 December 2017

354-366

1 reference

7 December 2017

5-6

1 reference

Systematic review on urine albumin testing for early detection of diabetic complications

7 December 2017

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201000136

Development and progression of nephropathy in type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS 64).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201000136

Global prevalence of diabetes: estimates for the year 2000 and projections for 2030

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201000136

Selection on albuminuria enhances the efficacy of screening for cardiovascular risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201000136

Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201000136

Renal outcomes with different fixed-dose combination therapies in patients with hypertension at high risk for cardiovascular events (ACCOMPLISH): a prespecified secondary analysis of a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201000136

Proteinuria as a surrogate outcome in CKD: report of a scientific workshop sponsored by the National Kidney Foundation and the US Food and Drug Administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201000136

Mechanisms involved in the genesis of diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201000136

Effects of intensive blood-pressure control in type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201000136

Reversal of lesions of diabetic nephropathy after pancreas transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201000136

10-year follow-up of intensive glucose control in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201000136

Long-term follow-up after tight control of blood pressure in type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201000136

Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201000136

Effect of lower targets for blood pressure and LDL cholesterol on atherosclerosis in diabetes: the SANDS randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201000136

New loci associated with kidney function and chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201000136

Metabolomics in evaluation of glucose disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201000136

Urinary proteomics in diabetes and CKD

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201000136

Multicentric validation of proteomic biomarkers in urine specific for diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201000136

A multi-marker approach to predict incident CKD and microalbuminuria

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201000136

Integrative bioinformatics analysis of proteins associated with the cardiorenal syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201000136

Biomarker candidates for cardiovascular disease and bone metabolism disorders in chronic kidney disease: a systems biology perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201000136

Cardiovascular networks: systems-based approaches to cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201000136

A dynamic network approach for the study of human phenotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201000136

Network properties of complex human disease genes identified through genome-wide association studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201000136

Identifying disease-specific genes based on their topological significance in protein networks

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201000136

The human disease network

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201000136

Identifying gene-disease associations using centrality on a literature mined gene-interaction network

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201000136

An integrative approach to characterize disease-specific pathways and their coordination: a case study in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201000136

Building disease-specific drug-protein connectivity maps from molecular interaction networks and PubMed abstracts

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201000136

HMDB: a knowledgebase for the human metabolome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201000136

DrugBank: a knowledgebase for drugs, drug actions and drug targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201000136

Linking the ovarian cancer transcriptome and immunome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201000136

Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201000136

Expression-based network biology identifies alteration in key regulatory pathways of type 2 diabetes and associated risk/complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201000136

Vascular endothelial growth factor (VEGF) in the pathogenesis of diabetic nephropathy of type 1 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201000136

Hypoxia response and VEGF-A expression in human proximal tubular epithelial cells in stable and progressive renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201000136

ArrayExpress update--from an archive of functional genomics experiments to the atlas of gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201000136

A guide to the Proteomics Identifications Database proteomics data repository

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201000136

Complement and coagulation: strangers or partners in crime?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201000136

Rationale for and study design of the sulodexide trials in Type 2 diabetic, hypertensive patients with microalbuminuria or overt nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201000136

Peroxisome proliferator-activated receptors in diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201000136

Gene expression profiling in glomeruli from human kidneys with diabetic nephropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201000136

Enhanced expression of Janus kinase-signal transducer and activator of transcription pathway members in human diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201000136

Improved elucidation of biological processes linked to diabetic nephropathy by single probe-based microarray data analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201000136

Gene expression profiles of human proximal tubular epithelial cells in proteinuric nephropathies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201000136

Characterization of diabetic nephropathy by urinary proteomic analysis: identification of a processed ubiquitin form as a differentially excreted protein in diabetic nephropathy patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201000136

Prediction of diabetic nephropathy using urine proteomic profiling 10 years prior to development of nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201000136

Two-dimensional fluorescence difference gel electrophoresis analysis of the urine proteome in human diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201000136

Ultraviolet and tandem mass spectrometry for simultaneous quantification of 21 pivotal metabolites in plasma from patients with diabetic nephropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201000136

Metabonomics research of diabetic nephropathy and type 2 diabetes mellitus based on UPLC-oaTOF-MS system

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201000136

Genetic loci influencing kidney function and chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201000136

Multiple loci associated with indices of renal function and chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201000136

Microarray analysis of multiple candidate genes and associated plasma proteins for nephropathy secondary to type 2 diabetes among Chinese individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201000136

Declining Incidence of Nephropathy in Insulin-Dependent Diabetes Mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201000136

Systems biology: opening new avenues in clinical research

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201000136

Proteomic analysis for the assessment of diabetic renal damage in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201000136

21 January 2018

Identifiers

DOI

10.1002/PRCA.201000136

1 reference

7 December 2017

1 reference